Article Details
Retrieved on: 2021-03-17 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
March 17, 2021 09:35 ET | Source: Lixte Biotechnology Holdings, Inc. More than 40 preclinical studies have found that Lixte's lead drug candidate LB- ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here